| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| J. E. Davis | CEO and President | 2025-11-05 | 7,143 | $175.57 | $1.25MSell |
| Gary M. Pfeiffer | Director | 2025-10-22 | 1,482 | $182.40 | $270.32kSell |
| Vicky B. Gregg | Director | 2025-10-21 | 70 | $189.08 | $13.24kBuy |
| Mark E. Delaney | SVP Chief Commercial Officer | 2025-10-21 | 15 | $189.08 | $2.84kBuy |
| Sam Samad | Executive Vice President CFO | 2025-10-21 | 68 | $189.08 | $12.86kBuy |
| Robert B. Carter | Director | 2025-10-21 | 6 | $189.09 | $1.13kBuy |
| Karthik Kuppusamy | SVP Clinical Solutions | 2025-10-21 | 15 | $189.08 | $2.84kBuy |
| Patrick Plewman | SVP for Diagnostic Services | 2025-10-21 | 46 | $189.08 | $8.70kBuy |
| Michael E. Prevoznik | SVP General Counsel | 2025-09-26 | 144 | $188.66 | $27.17kSell |
| Michael E. Prevoznik | SVP General Counsel | 2025-09-26 | 83 | $187.22 | $15.54kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 12.81% | 14,251,632 | $2.66B | Institution |
| Blackrock Inc | 8.99% | 10,002,035 | $1.87B | Institution |
| Price T Rowe Associates Inc | 6.30% | 7,005,990 | $1.31B | Institution |
| State Street Corp | 4.70% | 5,223,930 | $976.61M | Institution |
| Jpmorgan Chase Co | 3.88% | 4,317,391 | $807.14M | Institution |
| Boston Partners | 3.63% | 4,036,881 | $754.69M | Institution |
| Geode Capital Management LLC | 2.73% | 3,036,485 | $567.67M | Institution |
| Victory Capital Management Inc | 2.11% | 2,343,974 | $438.21M | Institution |
| Morgan Stanley | 2.06% | 2,286,910 | $427.54M | Institution |
| Dimensional Fund Advisors LP | 1.71% | 1,907,510 | $356.61M | Institution |